The company’s pipeline products also include Imsidolimab, an IL-36R antagonist, for the treatment of generalized pustular psoriasis; VTR-297, a small molecule histone deacetylase inhibitor to ...

Following after Boehringer in the GPP category is AnaptysBio, which has an IL-36 inhibitor called imsidolimab the phase 3 GEMINI-1 study for the disorder, with results due in the fourth quarter of ...

After hours: March 11 at 4:07:37 PM EDT Loading Chart for ANAB ...

Health care systems that adopted a higher volume of telehealth services less frequently used several low-value screening and diagnostic tests, according to results of a cohort study published in ...